These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection. Materson BJ Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412 [No Abstract] [Full Text] [Related]
7. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval? Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743 [TBL] [Abstract][Full Text] [Related]
8. The hypertensive heart: new observations and evolving therapeutic imperatives. Setaro JF J Clin Hypertens (Greenwich); 2001; 3(1):14-5. PubMed ID: 11416676 [No Abstract] [Full Text] [Related]
9. Hypertensive heart disease--significance of left ventricular hypertrophy. Schmieder RE J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190 [TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension and heart insufficiency]. Schwartzkopff B; Mundhenke M; Strauer BE Internist (Berl); 2000 Mar; 41(3):253-60. PubMed ID: 10789088 [No Abstract] [Full Text] [Related]
12. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases]. Baumgart P MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965 [No Abstract] [Full Text] [Related]
13. [Impact of arterial hypertension on the heart]. Herpin D Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398 [TBL] [Abstract][Full Text] [Related]
14. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy. Fyhrquist F; Dahlöf B; Devereux RB; Kjeldsen SE; Julius S; Beevers G; de Faire U; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Hille DA; Lyle PA; Edelman JM; Snapinn SM; Wedel H; Hypertension; 2005 Apr; 45(4):580-5. PubMed ID: 15790960 [TBL] [Abstract][Full Text] [Related]
15. Isolated systolic hypertension and the risk of vascular disease. Nawrot T; Den Hond E; Thijs L; Staessen JA Curr Hypertens Rep; 2003 Oct; 5(5):372-9. PubMed ID: 12948429 [TBL] [Abstract][Full Text] [Related]
16. Effects of a dual L/N-type calcium channel blocker cilnidipine on blood pressure, pulse rate, and autonomic functions in patients with mild to moderate hypertension. Kai T; Kuzumoto Y Clin Exp Hypertens; 2009 Oct; 31(7):595-604. PubMed ID: 19886857 [TBL] [Abstract][Full Text] [Related]
17. Coronary reserve and arteriolosclerosis in hypertensive heart disease. Schwartzkopff B; Strauer BE Z Kardiol; 2000; 89 Suppl 9():IX/132-5. PubMed ID: 11151783 [TBL] [Abstract][Full Text] [Related]
18. Effects of antihypertensive agents on the left ventricle: clinical implications. Díez J; González A; López B; Ravassa S; Fortuño MA Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026 [TBL] [Abstract][Full Text] [Related]
19. Treatment of diastolic dysfunction in hypertensive left ventricular hypertrophy. Bella JN Am J Hypertens; 2006 Sep; 19(9):937-8. PubMed ID: 16942936 [No Abstract] [Full Text] [Related]
20. Effects of 4 month exercise on left ventricular remodeling and autonomic nervous system in hypertensive patients. Zheng H; Xie N; Xu H; Huang J; Xie X; Luo M Panminerva Med; 2016 Mar; 58(1):1-7. PubMed ID: 25288325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]